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Human umbilical vein endothelial cells are responsible for maintaining and forming new vessels from 
existing ones, in a biological process called sprouting angiogenesis.  Sprouting angiogenesis is a crucial 
mechanism for the resolution of hypoxia and normal development of tissues. It also plays a key role in 
internal plague hemorrhages, which can lead to embolisms and other cardiovascular complications. 
Angiogenesis is also crucial for cancer development. Sprouting angiogenesis is initiated by hypoxic tissue 
excreted vascular endothelial growth factor gradient, which induces normal endothelial cells into either a 
proliferative stalk cell or a signal sensing tip cell phenotype. Both of these cell types depend on the rapid 
flow of lipids to their plasma membrane, either to form plasma membrane protrusions in tip cells or as new 
plasma membrane material in dividing stalk cells. This flow is envisioned to involve both vesicle-mediated 
and non-vesicular mechanisms. A major non-vesicular route of lipid transfer occurs at membrane contact 
sites via lipid transport proteins. Furthermore, lipids can be transported to the plasma membrane by the 
direct fusion of vesicles or endosomes with the plasma membrane 
 
This thesis set out to explore the role of two membrane contact site proteins,  
oxysterol-binding protein- related protein 2 and protrudin, in angiogenesis and lipid transfer. Their role was 
examined by RNA-sequencing transient knock-down samples of these proteins in HUVECs. The RNA-
sequencing data was examined by differential expression, gene ontology overrepresentation and gene set 
enrichment analyses. Gene expression analysis provided almost 10 000 significantly changed transcripts 
(adjusted p-values < 0.05), in each silenced cell type. The distribution of differentially expressed genes in 
oxysterol-binding protein- related protein 2 silenced cells, is skewed toward negative fold changes, 
whereas the distribution of  differentially expressed genes in protrudin silenced samples is normally 
distributed. The results also show significant changes in gene ontologies related to proliferation, cell cycle, 
angiogenesis as well as hypoxia in both sample types. Gene set enrichment analysis showed 
upregulation in angiogenesis related pathways, such as the PI3K-Akt and MAPK pathways, in both 
samples. Significant downregulation was present in cell cycle related pathways and cholesterol 
biosynthesis pathway in both ORP2 and protrudin silenced samples. 
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Ihmisen napanuoran suonen solujen primaari tarkoitus on huolehtia suonien kunnosta ja muodostaa uusia 
suonia vanhoista prosessissa, jota kutsutaan angiogeneesiksi. Angiogeneesin päätarkoitus on estää 
kudoksien ravinteiden sekä hapen puute ja se on kriittinen osatekijä kudosten normaalissa kasvussa. 
Angiogeneesillä on myös ratkaiseva rooli ateroskleroottiset plakkien sisäisissä verenvuodoissa, jotka 
saattavat johtaa embolioiden sekä muiden kardiovaskulaaristen komplikaatioiden muodostumiseen. 
Angiogeneesillä on myös ratkaiseva rooli monien syöpien kehityksessä. Uusien suonten muodostumisen 
laukaisee hapen puutteesta kärsivän kudoksen synnyttämä endoteelikasvutekijä gradientti. Tämä 
gradientti indusoi normaaleja endoteelisoluja muuttamaan fenotyyppinsä, joko jakautuviksi juurisoluiksi tai 
signaaleja aistiviksi kärkisoluiksi. Molemmat näistä solutyypeistä ovat riippuvaisia lipidien nopeasta 
virtauksesta solukalvolle, mitä ne käyttävät muodostaakseen solukalvo protruusioita tai uuden solukalvon 
rakenteeksi. Tämä lipidien virtaus voi tapahtua joko vesikelivälitteisen kuljetuksen tai ei-vesikelivälitteisen 
kuljetuksen avulla. Tärkeä ei-vesikelivälitteinen kuljetuksen muoto tapahtuu kalvokontaktipaikoilla, jossa 
lipidiensiirtoproteiinit siirtävät lipidejä kalvojen välillä. Lipidejä voidaan siirtää solukalvolle myös 
endosomien ja vesikelien fuusiolla. 
 
Tämän pro gradu -työn tarkoitus oli tutkia kahden kalvokontaktiproteiinin, oksysterolia sitovien proteiinien 
kaltaisen proteiini 2 sekä protrudiinin, roolia angiogeneesissä ja lipidien kuljetuksessa. Näiden kahden 
proteiinin shRNA-hiljennyksen vaikutusta HUVEC-soluissa tutkittiin RNA-sekvensoinnin avulla. RNA-
sekvensointi dataa analysoitiin geeni-ilmentymis-, geeniontologia ylirepresentaation- sekä geenijoukko 
rikastuma-analyyseilla. Geeni-ilmentymisanalyysi paljasti noin 10000 differentiaalisesti ilmentynyttä 
transkriptiä, joiden korjattu p-arvo oli alle 0.05.  Oksysterolia sitovien proteiinien kaltaisen proteiini 2 
hiljennetyissä näytteissä geenien ilmentymisen jakauma on vinoutunut ali-ilmentymisen puolelle, kun taas 
protrudiini hiljennetyissä näytteissä geeninen ilmentyminen oli normaalisti jakautunut. Geeniontologia 
ylirepresentaationanalyysin mukaan geeniontologiat, jotka liittyvät solujen jakautumiseen, solusykliin, 
angiogeneesiin sekä hapen puutteeseen, ovat tilastollisesti merkitsevästi yliedustettuja. Geenijoukko 
rikastuma-analyysi osoitti tilastollisesti merkittävää yli-ilmentymistä angiogeneesiin liittyvissä 
signalointireiteissä, kuten PI3K-Akt ja MAPK. Tilastollisesti merkittävää ali-ilmentymistä esiintyi solusykliin 
liittyvissä signalointireiteissä sekä kolesteroli biosynteesi metaboliareitissä. 
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Abbreviations 
ARF ADP ribosylation factor 
Dll4 Delta like ligand 4 
ER Endoplasmic reticulum 
EC Endothelial cell 
FFAT Two phenylalanines in an acidic tract motif 
GPL Glycerophospholipid 
HUVEC Human umbilical vein endothelial cells 
KD  Knockdown 
LTP Lipid transfer protein 
MCS Membrane contact site 
OSBP Oxysterol-binding protein 
ORP Oxysterol-binding protein- related protein 
PH Pleckstrin homology domain 
PM Plasma membrane 
PtdCho  Phosphatidylcholine 
PtdInsP Phosphatidylinositol phosphate 
RT-qPCR Reverse transcriptase quantitative PCR 
SNARE soluble NSF (N-ethyl-maleimide-sensitive fusion protein) attachment protein 
receptor 
VAMP Vesicle associated membrane protein 
VAP Vesicle associated membrane protein- associated protein 
VEGF Vascular endothelial growth factor 
VEGFR Vascular endothelial growth factor receptor 
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1 Introduction 
The aim of this thesis was to explore the gene expression profile of knockdown (KD) 
human umbilical vein endothelial cells (HUVEC) with reduced expression of protrudin and 
oxysterol-binding protein–related protein 2 (ORP2). Especially any changes in the 
biological functions and pathways related to angiogenesis and lipid metabolism were of 
interest. The effects of reduced expression of the aforementioned proteins were studied 
in basal conditions (normal ECGM 2 media, grown at 37 °C , 5% CO2), in order to find 
any perturbations that are due to the transient silencing of these proteins. The expression 
profile was characterized with RNA-sequencing data that were processed in a standard 
workflow, which is explained in the methods section. The count matrix produced from this 
workflow was controlled for shRNA off-target effects by a prediction algorithm, and any 
downregulated genes flagged by it were removed from the analysis. Further analysis 
performed on the RNA-sequencing data followed a standard workflow: Exploratory, 
differential gene expression, gene ontology overrepresentation and finally gene set 
enrichment analysis.  This workflow was chosen because it is the most logical in terms of 
finding meaningful changes in biological functions. Exploratory data analysis is done to 
quality control the data and gene ontology analysis was performed to see, which 
biological functions have changed. Gene set enrichment analysis is the final step to 
explore, which molecular functions have changed within the altered biological functions. 
This thesis will follow a familiar flow of topics. First an introduction to the main themes 
related to this thesis will be discussed. Then methods, as well as the results will be 
explained in detail, and the final sections of this thesis includes a discussion on the 
significance of the results and brief account of further experiments that could be 
performed. 
2 Background 
This section explains and elucidates the biological processes in which ORP2 and 
protrudin are involved in. First, endothelial cells (EC) and their intrinsic biological functions 
are discussed, in order to paint a bigger picture of the biological processes, where ORP2 
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and protrudin are of vital importance. Mainly their significance in regulation of cellular 
membranes during angiogenesis, which is one of the most crucial functions of ECs. After 
these sections, this thesis will dwell deeper into the molecular mechanisms, through 
which ORP2 and protrudin might be responsible for the control of plasma membrane (PM) 
modulation and therefore angiogenesis.  
 Endothelial cells 
ECs line the walls of blood and lymph vessels as a thin monolayer of cells. Their main 
function is to act as a barrier between the liquid and cells within the lumen and rest of the 
body, as well as the trafficking of molecules from the lumen to tissues. The most basic 
viable structure that ECs can form is a combination of ECs, basal lamina and pericytes. 
However, this structure can extend to more complex features, such as the combination 
of smooth muscles attached to the basal lamina, which are able to control the diameter 
of the vessel. ECs are also responsible for extending the vessel network of both blood 
and lymph vessels during development. This vessel network formation is called 
angiogenesis and without it tissues would die of hypoxia and malnutrition (Alberts, 
Johnson, Lewis, Morgan, & Raff, 2014, p 1235 - 1238).  
 Angiogenesis 
Since the hypothesis of this thesis is that ORP2 and Protrudin might play crucial roles in 
the modulation of the plasma membrane of HUVECs during angiogenesis, it is important 
to understand how HUVECs migrate to tissues and how angiogenesis is initiated. To this 
end the next chapter explores the mechanism, regulation and complications of 
angiogenesis.  
Usually angiogenesis is defined as the formation of new blood vessels, but it actually 
refers to the sprouting of new vessels from existing ones. The induction and formation of 
new vessel sprouts are dependent on the reaction of differentiated ECs to chemotactic 
stimulus. These tip cells are induced by a vascular endothelial growth factor (VEGF) 
gradient, which along with other angiogenic signals, guides them to invade tissues. The 
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VEGF gradient is triggered in tissues by the lack of nutrients or oxygen, and the 
transcription of VEGF is induced by increased levels intracellular hypoxia-inducible factor 
1α (Geudens & Gerhardt, 2011). The selection of which ECs turn into tip cells depends 
on how well they are able to bind VEGF to their VEGF receptors (VEGFR), as well as the 
expression level of the delta-like protein 4 (Dll4). The binding of VEGF to the VEGFR2 
begins a signaling process that represses neighbouring cells and stops them from 
becoming tip cells. This process turns the neighbouring cells into stalk cells through lateral 
inhibition that is mediated by the Dll4/Notch signalling pathway (Geudens & Gerhardt, 
2011). Stalk cells are proliferating ECs and their main function is to elongate the 
angiogenetic sprout, as well as form the blood vessel lumen. 
The aforementioned signaling process acts through the signalling pathway from VEGF to 
Notch, which is as follows: VEGF binding to VEGFR2 induces expression of Dll4, which 
in turn binds to Notch. The Notch intracellular domain is cleaved after Dll4 binding, and it 
initiates the Notch signalling pathway. This pathway downregulates the expression of 
VEGFR2, VEGFR3, NRP1, Dll4 and CXCR in the neighbouring cells, which inhibits them 
from becoming tip cells (Geudens & Gerhardt, 2011). This inhibition also leads to the 
upregulation of VEGFR1 and jagged1. VEGFR1 competes with the downregulated 
VEGFR2 for VEGF, which in turn reduces the expression of Dll4 in stalk cells. Jagged1 
acts as a defective notch ligand since it does not activate the notch pathway, this in turn 
leads to the competitive binding of jagged1 to the tip cells’ notch receptors, inhibiting 
notch activation, therefore keeping it in its transient tip cell phenotype. The whole process 
of vessel sprouting and the feedback process between tip and stalk cells can be seen in 
figure 1. 
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 A) VEGF gradient activates ECs (yellow) and primes them for sprouting. Out of the activated ECs 
only a few are selected as tip cells (green) due to VEGF/notch regulation. Lateral inhibition induces 
stalk cell (purple) phenotype in the tip cells’ neighboring cells, beginning vessel sprouting. Elongation 
of the sprout happens through the combination of tip cell guidance by angiogenetic signals and 
proliferation of stalk cells. B) Activation of VEGFR2 by VEGF begins the regulatory feedback loop, 
which keeps both tip and stalk cells in their respective transient phenotypes. VEGFR2 induced 
expression of the notch ligand Dll4 begins the activation of the notch pathway in stalk cells. This reduces 
the expression of VEGFR2 and Dll4 in stalk cells, which makes them less sensitive to VEGF. This in 
turn reduces the chances of the notch signaling pathway activating in other cells. Furthermore, the 
expression of other angiogenic signaling receptors (PDGFB, UNC5B) is downregulated and the 
expression of VEGF decoy receptors (VEGFR1) and defective notch ligands (Jagged1) is upregulated 
in stalk cells, which further cements their phenotype.  C) Soluble VEGFR1 further increases the VEGF 
gradient around the tip cell by binding to VEGF next to the tip cell and therefore decreasing the VEGF 
concentration in the lateral sides of the tip cell (adapted from Geudens & Gerhardt, 2011). 
The aforementioned feedback loop keeps both cells in their respective transient 
phenotypes until the VEGF gradient disappears, i.e. the hypoxia and nutrient deficiency 
in the tissue is resolved (Geudens & Gerhardt, 2011). 
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2.2.1 Guidance of sprouting angiogenesis 
New blood vessels cannot grow aimlessly toward the source of the VEGF gradient; 
therefore, a mechanism is needed to steer the new blood vessel to the correct direction. 
This guidance is the main responsibility of the tip cell that reacts to both the 
aforementioned VEGF gradient, as well as other signals from the tissue, which are 
sensed through lamellipodia and filopodia. Lamellipodia are extending PM sheets driven 
by a dynamic mesh-like actin structure, whereas filopodia are narrow PM protrusions with 
a core of filamentous actin. Both filopodia and lamellipodia are able to probe the cellular 
environment, and their response to environmental cues is either the depolymerisation or 
polymerisation of the actin filaments. This leads to the respective extension or retraction 
of the PM protrusion, depending on the environmental cue (Geudens & Gerhardt, 2011). 
Filopodia and lamellipodia can attach to the extracellular matrix by forming focal contacts. 
These attachment points allow cells to fix themselves to the extracellular matrix, which 
help them to migrate within tissues. Cell movement occurs with the contraction of 
intracellular actin microfilaments called stress fibres, which drag the cell toward focal 
contacts. Since cells are attached to the extracellular matrix, tip cells have to degrade it 
in order to invade tissues. The degradation of the extracellular matrix is aided by matrix 
metalloproteinases, which are expressed by tip cells. Metalloproteinases also regulate 
angiogenesis and are essential for the formation of the invading vessel in adults. It has 
also been demonstrated that membrane type-1 metalloproteinase is downregulated in 
stalk cells (Geudens & Gerhardt, 2011).  
2.2.2 Sprout elongation and lumen formation 
The elongation of the sprouting vessel happens through the proliferation of stalk cells and 
so far, two models have been proposed as the mechanism of elongation. One is the push 
model, where stalk cells are thought to push the tip cell deeper into tissues as they divide. 
Second is the pull model, which explains the elongation of the vessel by the tip cell pulling 
stalk cells with it, as it invades tissues. The pull model has gained more support over the 
years and studies have shown that the tip cell indeed exerts a pulling force on the stalk 
cells (Geudens & Gerhardt, 2011). In support of the push model, studies have also 
revealed that angiogenetic sprouts regress when stalk cell proliferation is decreased, 
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suggesting that the stalk cells are also pushing the tip cell forward (Geudens & Gerhardt, 
2011). This evidence would imply that a combination of the push and pull models could 
be responsible for the elongation of sprouts.  
A new sprout cannot function as a blood vessel without a lumen and how the vessel 
lumen is formed is still debated. However, there have been a few suggestions as to the 
mechanism of lumen formation during sprout elongation, which are usually referred to as: 
the intracellular vacuole coalescence, intracellular vacuole exocytosis and luminal 
repulsion models, which are illustrated in figure 2. Intracellular vacuole coalescence is 
described as the fusion of intracellular vacuoles within the cells. The fused vacuoles 
generate ever larger void within the cell until similar voids within other cells fuse together 
and create the lumen (Geudens & Gerhardt, 2011). Intercellular vacuole exocytosis 
explains lumen formation by the fusion of exocytotic vacuoles that make new intercellular 
space by fusing together outside the cells, eventually making enough space for a lumen 
to form between two cells (Geudens & Gerhardt, 2011). Lumenal repulsion is a 
mechanism where negatively charged CD34-sialomucins locate to VE-Cadherin sites 
between two cells. This creates enough electrostatic repulsion between the two cell 
membranes that VE-cadherin molecules relocate to the lateral side of the cells, and the 
membranes withdraw from their original positions. This essentially creates an intercellular 
void between the two cells, which then fuses with others like it in neighbouring cells, 
creating the lumen ( Geudens & Gerhardt, 2011). 
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 Different mechanisms of lumen formation by endothelial stalk cells during sprouting 
angiogenesis. A: Intracellular vacuole coalescence explains the lumen formation by the action of 
intracellular vacuoles fusing together forming the lumen within the cell. B: Intercellular vacuole 
exocytosis, explains lumen formation by the fusing events of exocytotic vesicles, which form the 
intercellular space C: Lumenal repulsion, explains lumen formation by the electrostatic repulsion (dot) 
of CD34-sialomucin molecules (orange), which leads to the depression of the apical membrane and 
relocation of VE-cadherin junctions (purple) (Adapted from Geudens & Gerhardt, 2011). 
The above examination of different aspects relating to angiogenesis is far from complete 
and much was left undiscussed. Angiogenesis is a hot research topic and some 
mechanisms related to it still remain a mystery. For example; Stalk cells continue 
proliferating even during lumen formation and how they are able to regulate the balance 
between tight EC junction and proliferation, in order to form a sealed and unobstructed 
lumen, requires more elucidation (Geudens & Gerhardt, 2011).  
2.2.3 Angiogenesis in disease 
Normal angiogenesis is crucial for a multitude of different physiological functions, such 
as wound healing and development, and it is vital that the effects of angiogenesis are 
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also reversible. Angiogenesis is a complex mechanism and therefore there are many 
points where perturbations can lead to deleterious effects. For example; continuous 
feedback process between tip and stalk cells, even in the absence of a VEGF gradient, 
can cause unwanted angiogenesis. Tip cells reacting to wrong cues might also steer the 
blood vessel to wrong direction, which can lead to vessels growing in wrong tissues at 
the wrong time. Some of these angiogenesis related diseases will be discussed in the 
following chapter. 
Cancer is probably one of the most common contexts where disturbed angiogenesis is 
discussed. This is probably due to the fact that one of the hallmarks of cancer is the 
tumours’ ability to initiate angiogenesis, and many modern cancer treatments try to 
perturb this. Angiogenesis is crucial for the survival of the tumour, since it needs oxygen 
and nutrients for rapid growth, as well as a route for spreading into other tissues i.e. 
metastasis. One of the treatments used for cancers is the anti-VEGF antibody 
bevacizumab, which is one of many FDA approved chemotherapies. Bevacizumab is 
used to treat advanced metastatic cancer, such as non-small cell lung cancer, renal cell 
cancer and colorectal cancers. For other cancers, for example hepatocellular carcinoma 
or thyroid cancer, VEGF receptor tyrosine kinase inhibitors are more commonly used 
(Moreno, Purushothaman, & Purushothaman, 2012; Potente, Gerhardt, & Carmeliet, 
2011). Unfortunately, cancers can circumvent VEGF stimulated sprouting angiogenesis 
in many ways: VEGF-independent vessel growth mediated through other proangiogenic 
signals and sprouting angiogenesis independent vessel growth mediated by, for instance 
vascular mimicry (Potente et al., 2011). Anti-angiogenesis treatment can also lead to 
severe complications, such as hypertension, thrombosis or embolisms, and therefore it 
might not be a viable treatment for cancer patients with atherosclerosis (Moreno et al., 
2012) 
Angiogenesis also has an important role in cardiovascular diseases, which with their 
many complications, are one of the leading causes of morbidity and mortality in the world 
(Moreno et al., 2012). In particular, atherosclerotic plaque formation initiates 
angiogenesis through hypoxia, which is caused by increased oxygen demand through 
inflammation and reduced oxygen supply, due to decreased blood flow by the thickening 
of vessel walls (Moreno et al., 2012). This can lead malformed capillaries growing within 
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the plaque, which in turn cause intraplaque haemorrhage. Intraplaque haemorrhage 
causes the plaque to become unstable, which can lead to pieces tearing from the plaque 
or the whole plaque breaking apart, eventually leading to infarctions. (Moreno et al., 
2012). Un-regressing angiogenesis can also pose problems to tissues, which have 
altered mechanical properties due to expanding vessel networks. ECs that are constantly 
stimulated by angiogenetic factors will keep growing vessel networks and in addition 
these networks keep expanding due to sprouting angiogenesis. This leads to a large 
network of small vessels that can rupture or collapse during mechanical stress leading to 
problems, such as heart failure (Moreno et al., 2012).  
 Membrane contact sites 
Angiogenesis is heavily reliant on the timely and accurate traffic of lipids to the PM of tip 
and stalk cells, which need them for extension of PM protrusions or proliferation and 
lumen formation. Non-vesicle mediated facilitators of this lipid flow are membrane contact 
site (MCS) proteins, which regulate the transfer of lipids within cells, but these proteins 
have not so far been researched in ECs. The existence of MCSs has been known for 
years, and they were first described in the late 1950s and early 1960s (Copeland, 1959; 
Porter, 1957; Robertson, 1960). Their role in biological functions has been a mystery, but 
some clarity on their function has emerged in the recent decades, which will be discussed 
in the following chapters. 
MCSs are usually described as membrane areas where two organelles, such as the 
endoplasmic reticulum (ER) and PM, are tethered together in close contact. However, not 
every instance where two membranes are in interaction can be described as a MCS. Four 
distinct criteria define an MCS (Prinz, 2014):  
• Two membranous organelles are in close contact (15–30 nm apart) through 
tethering proteins, which facilitate the trafficking of material between 
organelles  
• Membranes are in close proximity, but they do not fuse together at MCSs  
• Certain proteins as well as lipids are in abundance at MCSs 
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• The function and organisation of one, or both of the organelles is affected.  
The scope of this thesis will not allow the complete examination of different MCSs and 
trafficking of different molecules between different organelles, since the number of 
permutations is high. Therefore, the following sections will concentrate on discussing 
MCSs between ER, Golgi and endosomes, as well as the trafficking of lipids between 
them. Many areas, such as calcium exchange between ER, mitochondria and 
endosomes, will not be discussed and neither will the lipid exchange between ER and 
mitochondria. 
2.3.1 Tethering 
Tethering MCS proteins and protein complexes have an important function, not only in 
tethering two membranes together, but also in the maintenance of the MCSs. MCS 
proteins that act as tethers can be identified by three main functions: MCS proteins can 
mediate tethering independently, MCS proteins are regulated by feedback processes and 
MCS proteins can perform multiple functions (Prinz, 2014). MCSs are mostly maintained 
by several different proteins, for which an excellent example is a Saccharomyces 
cerevisiae ER to PM junction. Studies have demonstrated that at least six of the ER 
proteins need to be removed, in order to drastically reduce the tethering between ER and 
PM at the aforementioned junction. This junction is serviced by calcium- and lipid-binding 
proteins, such as Tcb1-3 and Ist2, as well as Scs2 and Scs22, which are the yeast 
orthologues of vesicle-associated membrane protein-associated proteins (VAP). This 
suggests that proteins at MCSs can mediate tethering independently of each other (Prinz, 
2014). PM-ER tethering through VAPs can, for example, be achieved by oxysterol-
binding protein (OSBP)- related proteins (ORP), which mediate the tether through their 
two phenylalanines in an acidic tract motif (FFAT) and pleckstrin homology (PH) domain. 
The PM-ER tethering is achieved by the VAP binding to the FFAT motif of ORP and, in 
turn, PH domain of the ORP binding to phosphatidylinositol phosphates (PtdInsP) in the 
PM (Prinz, 2014). Tethering at MCSs is also a regulated process. This fact was 
demonstrated by Mesmin et al., (Mesmin et al., 2013) when they proved the negative 
feedback regulation of ER-Golgi OSBP tethers. Mesmin et al. demonstrated that when 
PtdIns(4)P is enriched at Golgi, OSBP binds to it and begins transferring PtdIns(4)P to 
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ER, where Sac1 phosphatase mediated hydrolysis of PtdIns(4)P prevents it from moving 
back to Golgi. Once the levels of PtdIns(4)P drop at the Golgi, the tethering between Golgi 
and ER is reduced due to the dissociation of OSBP from Golgi. Tethering proteins and 
complexes seem to also have other functions than just tethering membranes. For 
example, mitofusin-2 is primarily responsible for mitochondrial fusion, but it also functions 
as an ER–mitochondrial tethering protein (Prinz, 2014). 
2.3.2 Membrane identity 
Many tethering MCS proteins are able to identify the membrane they interact with a 
multitude of different protein domains as described earlier. This identification process is 
crucial, because without it MCS proteins would not be able to perform their different 
functions correctly, including lipid transport. Cellular machinery identifies membranes 
through a combination of both specific lipids and proteins that are found in membranes. 
Hallmark protein families that give membranes their identity, have so far been recognized 
to be the Rab, ARF (ADP ribosylation factor) and SNARE (soluble NSF (N-ethyl-
maleimide-sensitive fusion protein) attachment protein receptor) protein families. The 
Rab protein family consists of proteins that are able to switch between an active GTP-
bound form and an inactive GDP-bound form, which is catalysed by GDP/GTP exchange 
factor (GEF), as well as GTPase-activating protein (GAP). The Rab family of proteins act 
as regulators of vesicular tethering, trafficking and fusion, as well as the movement of 
cellular structures (Stenmark & Olkkonen, 2001). Like Rabs, the ARF protein family is a 
part of Ras superfamily of GTP-binding proteins, which localize to cellular membranes, 
such as Arf1 to the Golgi or Arf6, which localizes to the PM and endosomes. The main 
function of this protein family is to recruit, for example, vesicle coat proteins and lipid 
modifying enzymes to the membranes, which in turn modulate the membrane 
composition and shape (Donaldson & Honda, 2005). SNARE proteins are responsible for 
the fusion of vesicles to membranes. These proteins include homologues of SNAP-25, 
syntaxin and vesicle associated membrane proteins (VAMP), which mediate vesicle 
fusion to membranes. The suggested mechanism of vesicle fusion involves zippering of 
SNAREs, which can be summed up as the intertwining event of membrane bound SNAP-
25 and syntaxin coiling together with a vesicle’s VAMPs. This sequence of events forces 
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the two membranes together, fusing them to one another (Chen, Scheller, & Medical, 
2001). 
PtdInsP have been shown to interact and attract proteins that have a phosphoinositide-
interacting domain, which localize them to PtdInsP containing membranes. Since PtdInsP 
can be phosphorylated in a number of positions in their inositol group, as many as seven 
different PtdInsP can be formed. This diversity of phosphorylated inositol groups can be 
used to differentiate membranes based on their PtdInsP populations. Composition of 
PtdInsP on the membrane leads to the diversification of lipid binding-proteins that bind to 
the membrane, essentially creating an identity for the membrane with the combination of 
lipids and lipid bound proteins. Furthermore, the Rab, ARF and SNARE protein families 
are able to regulate the production, localisation and dynamics of PtdInsPs, which in turn 
affect the localisation and activity of these proteins (Hammond et al., 2012; Jean & Kiger, 
2012; Kutateladze, 2010; Lemmon, 2008; Platre & Jaillais, 2016; M. L. A. Simon et al., 
2016). Even though PtdInsPs are crucial for many signalling events that govern a host of 
cellular activities, such as membrane trafficking, migration and signalling transduction, 
only trace amounts can be found in cellular membranes (Di Paolo & De Camilli, 2006). 
2.3.3 Protrudin and MCS proteins in endosome translocation 
Protrudin is one of many MCS proteins that are responsible for the regulation of 
endosomal translocation in the cell. These proteins are able to identify and tether their 
target membranes and endosomes through the proteins and lipids mentioned in the 
previous section. Protrudin belongs to the FYVE-finger family of proteins, which are 
mostly responsible for the localisation of endosomes. Protrudin is an ER transmembrane 
protein that interacts with VAPs, and it is also capable of binding to late endosome Rab7 
as well as Rab11. Neurite outgrowth is highly dependent on protrudin that functions as 
the mediator of Rab11 regulated membrane recycling. This membrane recycling of 
endosomes is critical for the quick and timely modulation of protruding membranes, such 
as the neurite growth cone.  Protrudin also has been shown to have a role in other neurite-
like protrusion forming biological processes in non-neuronal cells. Overexpression 
experiments of protrudin have proven that protrudin can induce kidney repair by initiating 
tubulogenesis (Zhang et al., 2017). Protrudin might also have a role in other biological 
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processes that depend on protrusion generation in cells, such as angiogenesis. Protrudin 
mediates endosomal translocation by binding to Rab7 via its low complexity region (LCR) 
and PtdIns(3)P, which is prevalent on endosomal membranes, through its FYVE domain. 
Protrudin regulates late endosome localisation by recruiting kinesin-1 to the MCS and 
transferring it to the late endosome membrane localized coiled-coil domain containing 
protein FYCO1. This protein is localized to membranes through Rab7 and PtdIns(3)P, 
which tether it to late endosomes. The main function of FYCO1 is to act as a link between 
the kinesin-1 and late endosomes. Linking of kinesin-1 via FYCO1 to late endosomes 
promotes their transport to cell periphery (Raiborg, Wenzel, Pedersen, & Stenmark, 
2016). Figure 3 illustrates the proposed mechanism of protrudin mediated late endosome 
translocation during neurite outgrowth. The localisation of endosomes, to and from the 
cell’s periphery, is therefore regulated by ER–endosome MCS tethering, which affects 
kinesin and dynein motor proteins. Moving the tether also moves both organelles, which 
can be seen as branching of ER tubules from the rough ER that are associated with 
endosomes and almost devoid of ribosomes. Almost half of early endosomes (53%) and 
nearly all late endosomes (99%) are tethered to the ER while they are trafficked in the 
cytosol. This suggests that the number of MCSs increases as the endosomes mature 
(Wijdeven, Jongsma, Neefjes, & Berlin, 2015). The composition of ER–late endosome 
MCSs is also in flux during the maturation process and various proteins that regulate the 
localisation of late endosomes can be seen at these sites. 
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 Protrudin mediated late endosome translocation in neurite growth cone. A: ER late endosome 
contact is established through protrudin PtdIns3P Rab7-GTP tether. Tethering leads to the recruitment 
of Kinesin-1, which binds to the late endosomal FYCO1. B: Kinesin-1 moves the late endosome toward 
the tip of the growth cone along microtubules. C and D: Late endosome fuses to the growth cone 
through vesicle fusion (adapted from Raiborg et al., 2016). 
The accumulation of late endosomes at the cell periphery or at the centre of the cell has 
been proposed to be dependent on cholesterol levels (Wijdeven et al., 2015). Only a few 
mechanisms describing cholesterol-dependent localisation of late endosomes have so 
far been proposed. One of these mechanisms is dependent on ORP1L mediated 
cholesterol sensing on the surface of late endosomes. ORP1L changes conformation 
when its ORD domain binds cholesterol, which allows it to form a complex with the Rab7 
GTPase, RILP (RAB-interacting lysosomal protein), the HOPS late endosome tethering 
complex and the dynactin-dynein motor complex. The formation of this complex results 
in the accumulation of late endosomes at the centre of the cell, mediated by minus-end 
trafficking along microtubules. In low cholesterol conditions, the ORD domain is not able 
to bind cholesterol and the conformation of ORP1L does not therefore change. The 
unchanged ORP1L conformation, in turn, keeps the FFAT motif free, and ORP1L binds 
to VAP instead of the aforementioned complex. FFAT motif binding to VAP then results 
in the reduced dynein facilitated minus-ended trafficking of late endosomes (Wijdeven et 
al., 2015). 
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Another protein that could be in charge of regulating the localisation of late endosomes, 
is the START domain-containing protein 3 (STARD3). Since STARD3 is capable of 
binding cholesterol with the START domain and it also contains a FFAT motif, it is very 
likely that it might have a role in sensing sterol at ER–late endosome MCSs. Some 
evidence that STARD3 is indeed associated with the localisation of late endosomes, has 
been obtained from KD experiments. These experiments have shown that STARD3 KD 
results in the trafficking of late endosomes to the cell periphery, as well as the reduction 
of actin patches on late endosomes. Furthermore, overexpression of STARD3 increases 
actin patches on late endosomes and locates them to the perinuclear region of the cell. 
The molecular machinery interacting with STARD3 is still unknown, but late endosomes 
seem to be associated to the actin skeleton through STARD3 (Alpy et al., 2013; Hölttä-
Vuori, Alpy, Tanhuanpää, & Jokitalo, 2005). 
2.3.4 Membrane lipids, transport between membranes and ORPs 
This thesis has touched upon most of the four main themes related to membrane contact 
sites, but how and what kinds of lipids are trafficked between membranes, still remains 
undiscussed. To this end, the following chapter will examine the diversity of lipids within 
the cell, then move on to explain how lipids are transported between membranes and 
finally discuss the role of ORPs in this mechanism. 
Membrane lipids 
The diversity of different lipids in eukaryotic cells is wide, and over 1000 different lipid 
species with varying functions and structures have been identified. Lipids function as the 
building blocks of cellular membranes and make up around 50% of the total membrane 
mass (Alberts et al., 2014, p 566). Lipids also act as an energy supply and storage, or as 
important factors in both signalling and intracellular trafficking. Lipids can be divided into 
eight distinct categories based on their structure and metabolic pathway of their 
production: fatty acids, glycerolipids, glycerophospholipids (GPLs), sphingolipids, sterol 
lipids, prenol lipids, saccharolipids and polyketides. The transport and metabolism of 
lipids is governed by roughly 5% of protein-coding DNA, and the most abundant lipid 
species are GPLs. They make up roughly 75 mol% of all cellular lipids, whereas the 
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second and third most abundant lipids are, sterol lipids at 12–14 mol% and sphingolipids 
at 8–12 mol%, respectively (Drin, 2014; van Meer, Voelker, & Feigenson, 2008). GPLs 
are so abundant because they are vital to the integrity of many membranes, which is 
evident from the fact that most intracellular membranes are composed of 40–44% of 
phosphatidylcholine (PtdCho). PtdCho is also vital for the PM of which 10–28 % is made 
up of PtdCho  (Alberts et al., 2014, p 571). Sterols are also very important membrane 
lipids, cholesterol being one of the most abundant PM lipids making up around 17 - 23% 
of lipids in the PM. The abundance of different lipids in different membranes is illustrated 
in table 1. 
 The amount of some lipids in different membranes (adapted from Alberts et.al, 2014, p 571) 
Lipid composition of different membranes 
 Proportion of lipids in % (w/w) 
Lipid Liver cell PM Red blood cell PM Myelin Mitochondrion ER E.coli  
Cholesterol 17 23 22 3 6 0 
Phosphatidylethanolamine 7 18 15 28 17 70 
Phosphatidylserine 4 7 9 2 5 trace 
Phosphatidylcholine 24 17 10 44 40 0 
Sphingomyelin 19 18 8 0 5 0 
Glycolipids 7 3 28 trace trace 0 
Other 22 14 8 23 27 30 
In addition to GPLs and sterols, sphingolipids, such as sphingomyelin and 
glycosphingolipids, can also be found in most eukaryotic membranes. The proportions of 
GPLs and sphingolipids are one factor that determines the rigidity of membranes. For 
example, membranes that have more sphingolipids are more gel-like, due to the fact that 
sphingolipids are able to pack more tightly. Whereas membranes, which have more 
GPLs, are more fluid compared to membranes that are abundant with sphingolipids, since 
GPLs are not able to pack so tightly (van Meer et al., 2008). Cholesterol can reduce the 
permeability of membranes to small water-soluble molecules; it prevents the hydrophobic 
tails of phospholipids from crystallizing and immobilizes fatty acyl chains in the 
surrounding region, making the membrane more rigid (Alberts et al., 2014, p 571).  
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Lipid transport between membranes and ORPs 
The transfer of most of the aforementioned lipids is facilitated by lipid transport proteins 
(LTP), which are a group of proteins that bind and traffic lipids between membranes, or 
from membranes to proteins. LTPs can be divided into at least 10 protein families 
according to many factors, one of them being their lipid transfer domain. Even though 
LTPs are structurally highly diverse, they still share common features and means of lipid 
transfer. All LTPs have a highly hydrophilic surface and a nonpolar amphiphilic tubular 
pocket in which the transferred lipids are placed. They also share a lid structure that keep 
the bound lipids protected from an aqueous environment. Furthermore, LTPs share many 
similar localisation domains, such as the aforementioned PH domain or FFAT motif, which 
help LTPs to attach to different membranes. These domains are not just acting alone, but 
LTPs often have two different localisation domains, which in unison help them bind 
membranes to a close apposition, in order for them to facilitate lipid transfer between the 
membranes (Chiapparino, Maeda, Turei, Saez-Rodriguez, & Gavin, 2016). Figure 4 
depicts 10 families of LTPs, their subcellular localisation and lipids they bind. 
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 A chart describing ten different lipid transport proteins families in different colors (inner circle), 
their localization patterns (lines and dots) and different lipids species that the lipid transport proteins 
have affinity to (outer circles with black bars) (adapted from Chiapparino, Maeda, Turei, Saez-
Rodriguez, & Gavin, 2016). 
Lipid transfer between different organelles and endosomes can happen either through 
direct diffusion between two closely apposed membranes, vesicular trafficking or by LTP 
mediated transport. The ability of LTPs, to bind and traffic cholesterol and PtdInsPs 
between Golgi and ER was already mentioned earlier, but LTPs are capable of 
transferring a host of different lipids over a number of membrane permutations. An 
important lipid trafficked between ER and endosomes is cholesterol, which is integral to 
the rigidity, stability and permeability of membranes, and therefore efficient trafficking of 
it is essential to cells. The suggested mechanism of lipid transfer between membranes is 
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usually described as the following: First the LTP tethers two membranes together; an 
excellent example of this are some of the ORPs, which bind two membranes into close 
proximity with their FFAT and PH domains. After the membranes have been brought into 
close apposition, a lipid is extracted from the membrane by the LTP. After extraction, the 
lipid is inserted into the hydrophobic pocket within the protein, which shields it from the 
cytosol. The lipid is then transferred over the gap between two membranes by the protein, 
which finally inserts it to the outer membrane of the receiving membrane (Olkkonen, 
2015). This mechanism is also illustrated in figure 5, which gives the outline of cholesterol 
traffic between Golgi and ER. 
 
  A model of ORP lipid transport mechanism at an ER – Golgi MCS. FFAT motif binds to VAP on 
the ER membrane and PH domain binds to PtdIns(4)P (PI4P) on the Golgi membrane. This action 
tethers the two membranes together, after which the transfer of cholesterol (C) can be mediated by the 
ORPs ORD domain. ORD extracts a cholesterol from the ER and ferries it over the membrane gap and 
places it in the Golgi membrane. ORD also extracts one PtdIns(4)P from Golgi to the ER Sac1 protein 
which then hydrolyses it to phosphatidylinositol. This cycle repeats until enough of PtdIns(4)P has been 
transported from the ER to Golgi and ORP disassociates from the Golgi membrane, which ends the 
transport of cholesterol against its concentration gradient (adapted from Olkkonen, 2015). 
Whether or not the mechanism of cholesterol transport between ER, PM and endosomes 
is similar to the above described mechanism is still uncertain. However, there is a strong 
case to be argued that similar mechanism between these membranes does exist. 
Endosomes and PM both contain PtdIns(4)P and cholesterol, and VAPs exist on 
endosomes, which would make it likely that ORPs could be facilitating the transfer of 
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cholesterol between PM and endosomes. Studies have also shown that  
phosphatidylinositol-4,5-bisphosphate 4-phosphatase localizes to endosomal 
membrane, which acts similar to Sac1 on endosomes (Niebuhr et al., 2002).  
ORP2 localises to the cytosol, lipid droplets and plasma membrane, and unlike number 
of other ORPs, ORP2 does not have a PH-domain so it is unable to tether its self to 
membranes with PtdIns(4)P. ORP2 has been shown to bind to the surfaces of lipid 
droplets and it can form tethering complexes with ER vesicle-associated membrane 
protein associated proteins that form tethers between ER and lipid droplets. Other 
evidence has shown that this complex is able to synthesise and inhibit the degradation of 
other lipids. Therefore, it would seem that the possible main function of ORP2 is to provide 
lipids and lipid precursors from lipid droplets to ER (Olkkonen, 2015). Two recent studies 
by Koponen et.al. and Wang et.al. showed that ORP2 is also able to control the 
subcellular localisation of cholesterol, especially its transport to the PM (Koponen et al., 
2019; Wang et al., 2019). The latter study also provided evidence that ORP2 exchanges 
cholesterol to phosphatidylinositol-4,5-bisphosphate at the PM (Wang et al., 2019) 
3 Aims 
The aim of this master’s thesis was to study the effects of ORP2 and protrudin KD in the 
biological functions of HUVECs through the exploration of RNA-sequencing data. The 
major hypothesis of this thesis was that KD of ORP2 or protrudin would hinder 
angiogenesis: In the case of ORP2 KD this might be due to hindered transport of 
cholesterol to the PM, due to the reduction of cholesterol traffic between endosomes and 
ER or endosomes and the PM. The protrudin KD might affect angiogenesis in a similar 
way that it impedes neurite outgrowths, i.e. the lack of endosomal transport. Other 
hypothesis includes; the lack of transport of other lipids to the plasma membrane due to 
protrudin KD and changes in lipid metabolism due to lack of lipid transport from lipid 
droplets and reduced control over cholesterol localization. 
• First aim was to produce transient KD HUVECs of OSBPL2 and ZFYVE27 
(i.e. protrudin) and sequence their transcriptome. 
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• Second aim was to process the base calls into high quality data, which could 
be used for downstream analysis. 
• Third aim was to interpret the sequencing data through multiple different 
analysis steps and mine for the changes in biological functions that are due 
to the silencing of OSBPL2 and ZFYVE27, especially any changes related to 
angiogenesis and lipid metabolism. 
4 Materials and methods 
The experimental work for this thesis was done according to the following flowchart (figure 
6), which illustrates the order of the experiments and analyses performed. 
 
 Flowchart outlining the experimental and analysis setup of the thesis 
More detailed information about each experimental step are described under each 
guiding headline and the bioinformatic methods are mainly discussed as the programs 
used in the analysis of the data and details of the parameters used in the analysis are 
omitted, in order to streamline this section. 
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Cell culture 
Primary cultures of HUVECs were purchased from PromoCell. Cell culture vessels for 
HUVECs were coated with a solution of fibronectin 10 µg / mL, gelatine 0.05% in 1X PBS 
for ½ – 2 hours and the solution was removed before any cells were seeded. HUVECs 
were grown in full ECGM2 media (PromoCell), trypsinization was done by washing the 
cells twice with 5 mL of warm 1X PBS and then adding 2 mL of Trypsin-EDTA (PromoCell) 
and coating the cells. After coating and a brief incubation, the Trypsin-EDTA was removed 
and cells were incubated at 37 °C, 5% CO2 for 2 – 3 minutes. Cells were collected to a 
fresh 15 mL Falcon tube by adding 2 – 5 mL of media to the culture vessel and pipetting 
the media back and forth on the vessel surface, after which the cells were counted with a 
BioRad TC20 Automated cell counter. Collected cells were pelleted by centrifuging for 5 
min at 800 RPM (Heraeus Megafuge 1.0). Media was removed, and cell pellets were 
resuspended in an appropriate amount of new media to achieve an optimal cell density 
for each experiment.  
Lentiviral KD in HUVECs 
Lentiviral particles were purchased from the University of Helsinki, FUGU core facility. 
Roughly 2.5*106 cells/mL of passage 4 HUVECs were resuspended into ECGM2 media 
with double supplements. To 1 mL of cell suspension, 750 µL of fresh lentiviral stock was 
added. 1.75 mL of the transduction mix was added to each fibronectin – gelatine coated 
6-well plate well and cells were incubated at 37 °C, 5% CO2 for 48 hours. Puromycin 
selection of HUVECs was done by changing the transduction media to ECGM2 full media 
containing 2,5 µg/ml (stock 10 mg/ml, 1:4000-dilution) of puromycin. Cells were selected 
over night at 37 °C, 5% CO2 and lysed next morning. 
RNA extraction 
RNA extraction was done according to the manufacturer’s instructions using the Quiagen- 
RNAeasy mini 50 kit (Quiagen) with the following modifications: DNAse digest was used, 
centrifugation (Heraeus Biofuge pico) at steps 6 and 7 were done at 13000 rpm, and 
samples were eluted to 30 µL of RNase free water. Samples were stored at - 80 °C. 
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Cell lysis, protein concertation estimation and Western blot analysis 
Lysis of cells for protein extractions was done by removing media, washing the cells with 
cold 1X PBS twice and then pipetting an appropriate amount of lysis buffer to the culture 
vessel. The composition of the lysis buffer can be found in table 3. 
 Composition of the lysis buffer used for the extraction proteins from HUVECs 
Lysis buffer composition for 10 ml of complete buffer 
Compound Concentration Volume 
1X Lysis buffer stock  
- 10 mM HEPES pH 7.6 
- 10% glycerol 
 8,6 mL 
- 150 mM NaCl   
- 0,5 mM MgCl2  
0,5 % Triton X-100 (Sigma) 10% 0,5 mL 
0,5 % sodium deoxycholate (Sigma) 10% 0,5 mL 
1:25 PIC (Roche) 2X 0,4 mL 
Cells were collected to a fresh tube and vortexed briefly before incubating on ice for 5 
minutes.  After, the tubes were centrifuged at 13000 rpm for 12 minutes at 4 °C, then cell 
lysate was removed to a new tube, and the sample was used for Western blotting. 
Protein concentration of each sample measured done according to manufacturer’s 
instructions (Thermo Fisher Scientific, Pierce BSA Protein Assay) using Thermo Fisher 
Scientific Multiskan FC equipment. Western blots were performed using 10% 
polyacrylamide gels that were made according to manufacturer’s instructions (BioRad 
TGX Stain-Free FastCast GELS). Samples with total protein amount of 10 µg and 1X 
laemmil sample buffer were boiled at 100 °C for 5 minutes and loaded onto gels, which 
were run in 1X TGST running buffer at 300 V (BioRad, PowerPac HV) for roughly 25 – 
30 minutes, until loading dye was either at the bottom of the gel or it had run through it. 
Gels were imaged before transfer and membranes after transfer using the BioRad 
ChemiDoc Touch Imaging System. Proteins were transferred from gels to PVDF 
membranes according to manufacturer’s instructions, using the Trans-Blot Turbo RTA 
Transfer Kit (LF-PVDF) and Trans-Blot Turbo Transfer System (BioRad). After transfer 
the membranes were blocked at RT for 30 minutes using an appropriate blocking-buffer 
(TBST-5% milk, TBST-5% BSA etc.) After blocking membranes were washed three times 
for 5 minutes using 1X TBST. Washed membranes were incubated with the primary 
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antibody (ORP2 or Protrudin) over-night at 4 °C and after incubation the membrane was 
washed as described before. The membrane was then incubated with and appropriate 
secondary antibody (for example, 1:2000 HRP-anti-rabbit in TBST-5% milk) for 2 hours 
at RT. After the incubation the membranes were once again washed and then incubated 
with developing solution according to manufacturer’s instructions (Thermo Fisher 
Scientific, Pierce ECL Western Blotting Substrate). Membranes were imaged every 
minute using the ChemiDoc, with a 5 minutes exposure.  
Next generation RNA sequencing 
Next generation RNA sequencing was performed by the University of Helsinki, functional 
genomics sequencing unit (FUGU). RNA quality control was done with the Tapestation 
(Agilent) according to manufacturer’s instructions. Library preparation was done with the 
NEBNext Ultra Directional II kit after polyA purification.  Library preparation quality control 
was also performed using the Tapestation. Sequencing was done with the Illumina 
NextSeq 500 sequencer (NextSeq High Output 1 x 75 bp). 
Bioinformatics 
Trimming, alignment, read counting and differential expression analyses were performed 
using the Chipster suite (Kallio et al., 2011). The following workflow was used to generate 
the differential expression data: FASTA files were quality controlled using FastQC (A. 
Simon, 2010) and trimmed using Trimmomatic (Bolger, Usadel, & Lohse, 2014). Single-
end reads were aligned to the reference genome GRCh38, with STAR (Dobin et al., 
2012). Mapped reads were counted using HTseq (Pyl, Anders, & Huber, 2014), with the 
ENSEMBL GRCh38 annotation file (Zerbino et al., 2018) as a reference. Differential 
expression analysis was performed using DESeq2, with a cut-off value for Benjamini-
Hochberg adjusted p-values of 0.05 (Love, Huber, & Anders, 2014).  
Short hairpin RNA off-target effects were verified by acquiring all 3’ UTR sequences for 
each gene Ensemble ID from downregulated genes. The transcript sequences were 
annotated to Ensemble IDs with biomaRt (Brazma et al., 2005; Durinck, Spellman, Birney, 
& Huber, 2009) and then the reverse compliment of the seed sequence of each shRNA 
25 
 
 
(table 4) was referenced against the 3’UTR sequences to find a match, with an inhouse 
developed R script (appendix 1). Each shRNA seed sequence was assumed to work in a 
similar manner to miRNA seed sequences. The performance of the inhouse developed R 
script was also compared against a more robust shRNA off-target predictor, GESS 
(Sigoillot et al., 2012; Yilmazel et al., 2014) 
 The shRNAs sequences used to silence ORP2 and protruding in HUVECs, seed sequence 
highlighted in yellow. 
shRNA sequences used for ORP2 and protrudin (ZFYVE27) knockdown 
Gene shRNA sequence 
OSBPL2 CCGGCGGGAATGATTGACTTAGACACTCGAGTGTCTAAGTCAATCATTCCCGTTTTTTG 
 
ZFYVE27 CCGGGTGTAACCAGACCTTGAGCAACTCGAGTTGCTCAAGGTCTGGTTACACTTTTTTG 
 
Gene ontology overrepresentation analysis was performed using GOrilla (Eden, Lipson, 
Yogev, & Yakhini, 2007; Eden, Navon, Steinfeld, Lipson, & Yakhini, 2009). Gene set 
enrichment analysis was performed using either the Pathview web application, GAGE R 
package or consensuspathdb (Brouwer, Blanchard  Jr, Luo, Pant, & Bhavnasi, 2017; 
Kamburov et al., 2011; Luo, Friedman, Shedden, Hankenson, & Woolf, 2009) and results 
were mapped onto KEGG-pathway graphs using Pathview (Brouwer & Luo, 2013; 
Kutmon et al., 2015; van Iersel et al., 2008) or Wikipathway maps using Pathvisio (Bohler 
et al., 2015; Pico et al., 2011).  
5 Results 
Western blot analysis, quality control and exploratory data analysis are discussed first. 
Exploratory data analysis is crucial, since if the samples cannot be separated from each 
other based on the gene expression, then downstream analysis of the data would not 
produce meaningful results. The shRNA target prediction is the next step in insuring that 
the data is of high quality and it is also needed to distinguish real downregulation from 
off-target effects. Gene ontology overrepresentation analysis is discussed next, and it is 
a convenient way to get biologically relevant information from the data. Not only does it 
compare your data against curated data sets, but it also produces intuitive plots, which 
help to narrow down biological functions that have been affected by the gene silencing. 
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Gene set enrichment analysis is the final step of the process and it can be used to find 
affected pathways within a biological function. Gene set enrichment analysis further 
narrows down the search for biologically meaningful changes due to the gene silencing. 
It is important to note that all the tools used to derive the results use probability in one 
way or another, which means that false discoveries are possible, and therefore some 
healthy scepticism should be practiced when interpreting the results. 
Western blot and exploratory data analysis 
Western blot analysis of ORP2 and protrudin lentiviral KD samples show that reduction 
of mRNA levels can also be seen at the protein level, within the time span of an ordinary 
KD experiment i.e. approximately 72 hours (figure 7). Levels of actin can be seen to be 
steady in each sample and therefore it is reasonable to conclude that the reduction in the 
intensity of the bands in the gel is due to the reduction in the protein level, and not due to 
sample loading error. Level of ORP2 has been reduced significantly more compared to 
control than the level of protrudin, but a reduction can be seen also for the latter. 
 
  Levels of ORP2, protrudin and actin in both control and lentiviral KD samples. Data provided by 
Annika Koponen 
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Quality control plots from multiQC illustrate clearly that the sequence data produced by 
FUGU was of excellent quality (figure 8). Overwhelming majority of bases are above the 
phred score of 30 and the mean phred score in all base positions is above 30.  
 
 MultiQC report plots of the per sequence quality score and mean quality score of bases in all 
sequencing lanes (n = 3, technical replicates = 4, 4 lanes per replicate). 
Other quality control metrics (table 5) also illustrate that the quality of the sequencing data 
is excellent. For example, mean sequences length is above 70, mean GC content is 51%, 
mean per base N content is less than 5% along the total length of the sequence and 
adapter contamination is less than 0.1% in all samples. 
 MultiQC quality metrics of sequencing data 
MulitQC quality metrics in each sample type 
Sample ORP Protrudin Control 
Mean GC% 51 
 
 
51 
 
51 
 
Mean per base N content <5% 
 
<5% 
 
<5% 
 
Mean adapter content <0.1% 
 
<0.1% 
 
<0.1% 
 
Mean sequence length >70 >70 >70 
The above metrics show that the sequencing data is of high quality and reliable, but to 
make the data even more reliable the sequences were subject to Trimmomatic quality 
control. Mainly all bases with a phred score lower than 30 were deleted, which removed 
roughly 0.6% of all bases. 
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Exploratory data analysis was performed before further analysis, to see whether or not 
there was any separation and grouping between the samples. First a principle component 
analysis (PCA) -plot was generated to visualise if there was any variation between the 
samples. As can be seen from figure 9, the samples are separating well and most 
samples are closely clustered together within their own group, except for the control 
samples, which show more separation within the group than the other sample types. 
Figure 9 also shows that the separation between the silenced samples is sufficient, 
therefore we can draw conclusions on the effects of silencing of either ORP2 or protrudin. 
Figure 9 also shows that protrudin samples differ more from the controls than the ORP2 
samples. 
 
 PCA plot of rlog normalized counts.  
The same effect can be seen in the hierarchical clustering heatmap, which plots the 
variation in the 100 most variable genes in the samples (figure 10).  
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 Heatmap of 100 most variable genes from rlog normalized counts in all samples. 
Both the PCA plot and the heatmap show separation between the samples, especially 
the silenced samples from the controls. Grouping of similar samples is also distinct, 
therefore we can assume that we can differentiate samples from controls, and each other.  
Next two volcano plots were produced to visualize the distribution of genes relative to the 
-log10 of the adjusted p-value and log2 -fold change, in the silenced samples. As we can 
see from figures 11 and 12, the fold change has not been substantial in most genes and 
we can see most of them cluster between the fold changes -1 – 1.  
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 Volcano plot of significantly changed genes in ORP2 silenced samples, where x-axis represents 
the log2 fold change and y-axis depicts the -log10 of the adjusted p-value. Top 20 down- and 
upregulated genes have been annotated with arrows. Blue dots represent genes with absolute log2 
fold change of more than 1.5, orange dots represent genes with absolute log2 fold change of less than 
1.5 
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 Volcano plot of significantly changed genes in ORP2 silenced samples where x-axis represents 
the log2 fold change and y-axis depicts the -log10 of the adjusted p-value. Top 20 down- and 
upregulated genes plotted and annotated with arrows. Blue dots represent genes that with absolute 
log2 fold change of more than 1.5, orange dots represent genes with absolute log2 fold change of less 
than 1.5 
The fact that most genes cluster between -1 – 1 log fold change is due to assumptions in 
the DESeq2 algorithm, mainly the expectation that most genes are not differentially 
expressed, and the variation of low expressing genes is reduced with normalisation. The 
top 20 most affected genes by the KD of ORP2 or protrudin can be seen plotted in figures 
11 and 12. These plots were generated from data where genes that were flagged as 
shRNA off-targets had been removed, see section “4.2 Prediction of shRNA off-target 
effects” for more information. There seems to be a difference in the distribution of genes 
in the volcano plots between the samples. In ORP2 more genes seem to have negative 
log2 fold changes than in protrudin samples where the distribution is more equal. There 
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also seems to be more downregulated genes with fold changes smaller than -1.5 in ORP2 
samples than in protrudin samples. It is also notable that in ORP2 samples there are 
fewer genes with positive fold changes and the largest positive fold changes have 
relatively smaller adjusted p-values, whereas in protrudin samples there seems to be 
more variance in the adjusted p-values. There does not seem to be an obvious pattern in 
the top 20 most down- and upregulated genes in either of the sample types , but there 
seem to be a few kinases and genes related to cell cycle within them. Table 6 illustrates 
the expression and adjusted p-values of oxysterol binding proteins in both samples 
 Expression of oxysterol binding proteins in ORP2 and protrudin KD samples. Differences in 
expression between the samples have been highlighted in yellow and genes upregulated in both 
samples have been highlighted in red 
Expression of oxysterol binding proteins that were significantly differentially expressed in ORP2 
and protrudin KD samples 
Symbol Log2 fold change Adjusted p-value 
Sample ORP2 protrudin ORP2 protrudin 
OSBP - 0,28 NA 1,86E-09 NA 
OSBP2 - 0,39 - 1,3 1,17E-05 1,07E-39 
OSBPL1A - 0,74 - 0,44 4,74E-32 6,29E-13 
OSBPL2 - 1,32 0,45 5,41E-89 4,21E-17 
OSBPL3 - 0,5 - 0,92 2,43E-23 4,68E-67 
OSBPL5 NA - 0,52 NA 6,54E-15 
OSBPL6 - 0,44 - 0,76 9,34E-05 2,46E-11 
OSBPL7 0,42 NA 0,02091 NA 
OSBPL8 0,65 1,08 8,70E-52 9,52E-125 
OSBPL9 - 0,27 0,23 6,33E-11 2,05E-07 
OSBPL10 0,51 0,27 2,16E-32 6,67E-09 
OSBPL11 NA - 0,46 NA 6,58E-14 
There has been clear downregulation in many of the oxysterol binding proteins in both 
samples. The pattern of expression seems to be very similar in both samples and only 
OSBPL2 and OSBPL9 differ between them. Differences in expression of OSBPL2 are 
most likely due to the KD of ORP2. 
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Prediction of shRNA off-target effects 
Prediction of shRNA off-target effects was done with an inhouse developed R script, 
which can be found in appendix 1, or with GESS. List of top 10 genes in which the seed 
sequence was found can be found in table 7. There seems to be no abnormalities in the 
distribution of these adjusted p-values and log2 fold changes. There also appears to be 
no apparent pattern in the genes where the seed sequence was found. 
 Ten most downregulated genes with the seed sequence in ORP2 and protrudin samples 
Top 10 downregulated genes where the shRNA seed sequence was found in ORP2 and protruding 
KD samples 
ORP2 Protrudin 
Gene symbol Log2 fold change Adjusted p-value Gene symbol 
Log2 fold 
change Adjusted p-value 
GTSE1 -4,09 4,03E-158 ELMOD1 -3,72 1,57E-33 
SRL -1,98 9,72E-10 CDC6 -3,5 3,83E-124 
SDCBP2 -1,66 2,57E-24 ACOT11 -2,84 4,01E-86 
APOL4 -1,55 4,26E-09 CLSPN -2,68 1,29E-73 
USP2 -1,46 5,68E-07 EMP2 -2,42 9,43E-100 
PLAC8 -1,41 8,63E-17 GNAI2 -2,06 <8,49E-260 
CDH4 -1,33 6,62E-06 DLAT -1,93 8,49E-260 
SZRD1 -1,22 1,78E-238 C1RL -1,76 1,04E-121 
ELK3 -1,04 1,51E-98 INSIG1 -1,7 1,67E-160 
RHPN2 -0,97 1,00E-05 CYSLTR2 -1,7 1,24E-05 
Total number of significantly 
downregulated genes with the 
seed sequence 
80 Total number of significantly 
downregulated genes with the 
seed sequence 
96 
GESS, a more robust shRNA off-target predictor, was also used to find possible off-
targets. Results of top ten most downregulated unique genes found by the GESS 
algorithm can be found from table 8. The obvious difference between the inhouse 
developed R script and GESS, is that there are fewer off-targets found with the GESS 
algorithm. The less robust R scripts finds approximately 100 total off-targets from only the 
significantly downregulated genes, whereas GESS finds approximately 45 off-targets 
from every known transcript in the ENSEMBL database. 
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 Top 10 GESS identified downregulated off-targets in significantly changed genes.  
GESS predicted, top 10 significantly downregulated, shRNA off-targets in ORP2 and protrudin 
silenced samples 
ORP Protrudin 
Gene symbol Log2 fold change Adjusted 
p-value 
Gene symbol Log2 fold change Adjusted 
p-value 
KLF8 -2,16 3,63E-30 KLF8 -2,06 2,57E-26 
USP2 -1,46 5,68E-07 KCNN3 -1,82 2,14E-35 
KCNN3 -0,96 7,15E-15 CD47 -0,96 1,71E-72 
ZFP36L1 -0,86 1,89E-97 USP2 -0,86 5,60E-03 
LPP -0,83 2,90E-32 BCL10 -0,65 5,71E-36 
MEX3D -0,82 4,20E-110 ZNF704 -0,63 7,44E-23 
HDAC4 -0,66 1,95E-17 SSR1 -0,46 6,02E-29 
BCL10 -0,56 2,23E-33 UCHL5 -0,38 9,89E-10 
UCHL5 -0,54 1,64E-20 ERN1 -0,32 1,58E-07 
HOOK3 -0,51 3,06E-13 ZNHIT3 -0,24 3,39E-04 
Total number of off-targets in 
significantly downregulated genes 
15 Total number of off-targets in 
significantly downregulated genes 
13 
These results show that there are only a few off-targets for each shRNA, and they do not 
seem to be affecting many critical biological pathways or functions, therefore further 
analysis can be assumed to be essentially unaffected by the off-target effects of shRNA. 
Gene ontology overrepresentation analysis 
Cellular proliferation seems to be affected in both samples. These terms seem to be 
heavily skewed towards cellular processes that are associated with the overall health of 
the cells. For example, in both protrudin and ORP2 samples, mRNAs involved in cell 
motility, cell cycle, cell division and mitotic cell cycle are significantly affected. These 
examples can be seen in table 9. GO analysis also shows a clear enrichment in terms 
related to angiogenesis, although the enrichment is not as large as compared to the 
aforementioned examples, but there are statistically significant changes in these GO 
terms. 
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 Biological function GO terms, their descriptions, FDR and enrichment of terms that are 
associated with cell cycle, protein phosphorylation and angiogenesis in ORP2 and protrudin KD 
samples. 
Selection of relevant, significantly changed GO-terms in ORP2 and protrudin KD samples 
GO term Description FDR Enrichment 
GO terms in ORP2 KD samples 
GO:0000278 mitotic cell cycle 7,92E-07 4,47 
GO:0008283 cell proliferation 5,32E-03 2,16 
GO:0048870 cell motility 3,69E-04  1,69 
GO:0007049 cell cycle 1,16E-03 2,28 
GO:0051301 cell division 1,29E-10 4,32 
GO:0006468 protein phosphorylation 1,75E-02  1,77 
GO:0001525 angiogenesis 2,86E-04 2,15 
GO:0045765 regulation of angiogenesis 8,32E-04 2,13 
GO:1903670 regulation of sprouting angiogenesis 3,78E-02 2,77 
GO:0045766 positive regulation of angiogenesis 3,97E-02 2,19 
GO:1904018 positive regulation of vasculature development 1,95E-02 2,19 
GO:1901342 regulation of vasculature development 3,76E-04 2,13 
GO:0036293 response to decreased oxygen levels 3,56E-02 1,96 
GO:0070482 response to oxygen levels 1,20E-02 1,95 
Total number of enriched GO terms 275 
GO terms in protrudin KD samples 
GO:0000278 mitotic cell cycle 6,06E-11 3,65 
GO:0008283 cell proliferation 5,43E-07 1,89 
GO:0048870 cell motility 2,35E-05 1,65 
GO:0007049 cell cycle 1,43E-04 1,95 
GO:0051301 cell division 6,02E-07 2,13 
GO:0001932 regulation of protein phosphorylation 1,00E-08 2,11 
GO:0001525 angiogenesis 1,02E-04 2,27 
GO:0045765 regulation of angiogenesis 2,87E-02 2,04 
GO:1903670 regulation of sprouting angiogenesis 3,11E-03 6,27 
GO:0090049 regulation of cell migration involved in sprouting angiogenesis 5,18E-03 7,45 
Total number of enriched GO terms 293 
Other biological processes that seem to be similar between ORP2 and protrudin KD 
samples are related to the phosphorylation of proteins. 
There seem to be significant changes in biological processes involved in cell cycle, 
angiogenesis and protein phosphorylation in both sample types. Therefore, there is cause 
to suspect that there might also be significant changes within the pathways that are 
related to these processes. Since GO-analysis does not predict whether or not the 
biological process has been up- or downregulated, gene set enrichment analysis has to 
be performed in order to find the molecular changes within these biological processes. 
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Gene set enrichment analysis with Wikipathways gene sets 
Gene set enrichment analysis was performed to see which pathways have changed the 
most due to silencing. Table 10 shows the relative change of the pathways compared to 
control. These results show that pathways related to angiogenesis are significantly 
upregulated in both samples. Both samples show significant upregulation in the VEGFA 
– VEGFR2 signaling pathway, PI3K-Akt and MAPK signaling pathways. These results 
would suggest that there is significant upregulation in angiogenesis since these three 
pathways are intertwined and their upregulation is predicted to increase angiogenesis. 
The focal adhesion pathway also shows significant upregulation in both samples, which 
could be argued to be related to angiogenesis. Samples differ in the upregulation of their 
pathways as in ORP2 the angiogenesis and matrix metalloproteinases pathways are 
significantly upregulated, whereas in protrudin samples the brain-derived neurotrophic 
factor (BDNF) signaling and PDGFB pathways are upregulated. These results are in line 
with the results acquired from gene ontology overrepresentation analysis. 
Most notable downregulated pathway in both samples is the cholesterol biosynthesis 
pathway and pathways that are related to cell cycle, such as cell cycle pathway, DNA 
replication, G1 to S cell cycle control pathways, to name a few. Pathways related to cell 
cycle seem to be consistent with the results obtained from the gene ontology 
overrepresentation analysis. There seems to be a difference between the samples in 
some metabolic pathways, mainly that the protrudin samples have significant 
downregulation in glycolysis related pathways and other lipid metabolism pathways, 
whereas ORP samples seem to have more downregulation in amino acid related 
pathways. Good examples of these are the TCA cycle, glycolysis and gluconeogenesis 
pathways in protrudin samples, and amino acid metabolism, urea cycle and metabolism 
of amino groups pathways in ORP samples. A selection of these pathways and their p- 
and q-values can be found in table 10. Appendix 3 figures 1 and 2 illustrate all up- and 
downregulated pathways in each sample, which have a p-value of less than 0.01. 
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 Selection of five down- and upregulated gene sets in ORP2 and protrudin silenced samples. 
Selection of top 5 up- and downregulated pathways in ORP2 and protrudin KD samples 
Pathway p-value q-value regulation 
Pathways affected by the ORP2 silencing 
Cell Cycle 1,49E-21 2,46E-19 - 
DNA Replication 5,57E-17 4,60E-15 - 
Cholesterol Biosynthesis Pathway 6,68E-08 2,45E-06 - 
G1 to S cell cycle control 1.24E-12 8.20E-11 - 
Amino Acid metabolism 9,26E-07 2,67E-05 - 
VEGFA-VEGFR2 Signaling Pathway 1,74E-07 1,91E-05 + 
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway 6,11E-06 2,01E-4 + 
MAPK Signaling Pathway 2,25E-05 5,70E-4 + 
Matrix Metalloproteinases 1,60E-3 1,20E-2 + 
Angiogenesis 7,17E-3 3,64E-2 + 
Pathways affected by the protrudin silencing 
DNA Replication 5,75E-16 9,72E-14 - 
Cell Cycle 1,61E-14 1,36E-12 - 
G1 to S cell cycle control 6,96E-7 2,13E-5 - 
Cholesterol Biosynthesis Pathway 4,67E-4 5,44E-3 - 
Glycolysis and Gluconeogenesis 2,31E-5 4,59E-4 - 
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway  4,24E-5 1,60E-3 + 
VEGFA-VEGFR2 Signaling Pathway 4,00E-4 7,12E-3 + 
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway 8,63E-4 1,12E-2 + 
MAPK Signaling Pathway 1,25E-3 1,30E-2 + 
PDGFR-beta pathway 7,59E-3 4,20E-2 + 
Since the most interesting pathways related to the hypothesis of this thesis are the 
angiogenesis, PI3K-Akt, MAPK and cholesterol biosynthesis pathways, the gene 
expression of the genes within these pathways was plotted onto pathway maps with 
PathVisio. Illustrated in figure 13 is the simplified angiogenesis pathway map, which also 
includes parts of the PI3K-Akt and MAPK pathways. 
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 Simplified pathway map of the main components related to angiogenesis. Differences in the 
expression of genes between ORP2 and protrudin samples have been displayed in the following 
manner: Top most gene symbol represent the gene expression in ORP2 samples and below is 
displayed its counterpart in protrudin samples, which has also been underlined with red. For example, 
the sTIE2 and TIE2 genes have been upregulated in ORP2 samples but downregulated in protrudin 
samples. Significantly changed genes, have been plotted on the map and their relative fold changed is 
displayed as red for upregulation and as green for relative downregulation 
The angiogenesis pathway map shows that the Akt1, NOS and MAPK1 genes are 
downregulated in both samples, which could suggest reduced angiogenesis. They also 
show that most upstream genes such as PI3K, SMAD1 and PLCG1 are upregulated in 
both samples. The angiogenesis pathway differs in these two samples in the regulation 
of FAK, TIE2, FLT1 and Ang1.  
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 Cholesterol biosynthesis pathway map. Differences in the expression of genes between ORP2 
and protrudin samples have been displayed in the following manner: Top most gene symbol represent 
the gene expression in ORP2 samples and below is displayed its counterpart in protrudin samples, 
which has also been underlined with red. For example, the SC5dl has not been differentially expressed 
in ORP2 samples but it is upregulated in protrudin samples. Significantly changed genes have been 
plotted on the map and their relative fold change is displayed as red for upregulation and as green for 
relative down regulation. 
The cholesterol biosynthesis pathway in figure 14, shows clear downregulation in both 
samples and only one gene, SC5DL, in protrudin samples is upregulated.  
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6 Discussion                                                                                                                                                                                                                                                                                                                 
Only the major results of this thesis will be discussed in the same order as they appear 
in the results section. This section will be presented as guiding headers that are either 
similar or identical to the sub headers of the results section. 
Exploratory data analysis 
Exploratory data analysis provided results that could be expected from a standard RNA-
sequencing experiment. Considering that there are thousands of genes that are used in 
PCA and heatmaps to differentiate the samples, there is little chance that there would be 
no clear separation between the samples. This is due to the enormous volume of data 
that is used for the differentiation. As mentioned already, the variation in the top 100 most 
variable genes seems to be very similar within all samples, but this is most likely due to 
normalisation that reduces variation in the gene expression data. This effect can be seen 
the DESeq2 dispersion estimation in figure 15, which shows the real distribution of genes 
in black, normalized distribution in blue and the fitted curve, which is used to produce the 
normalisation. 
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 Dispersion estimation of ORP2 samples that shows the original distribution of gene expression 
in black, normalized distribution in blue and the fitted curve used to normalize the expression data.  
The overall distribution of the gene expression results is as expected. The expression 
changes for most genes are not drastic and as noted before, most of the significantly 
changed genes cluster between fold changes of -1 – 1. We can see that most transcripts 
have not been significantly changed as only around 5% (~10 000) of all known transcripts 
(208 689) have changed significantly. This result could also be due to the bias of DESeq2, 
which assumes that most genes are not differentially expressed. Why the expression of 
genes in ORP2 silenced samples, displayed in the volcano plot, is more skewed toward 
downregulation and why the most upregulated genes have such similar smaller -log10 
adjusted p-values, could be just due to chance. This effect could also be due to the 
silencing of ORP2, which could affect the cells transcriptional machinery and therefore 
there would be less transcripts in general. The same effects seen in the distribution of 
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genes in ORP2 cannot be seen in protrudin samples, which is very standard and there 
are no obvious patterns in the distribution of differentially expressed genes.  
Examination of the regulation of oxysterol binding proteins in both samples are in a stark 
contrast to a previous study performed by Kentala et al. (Kentala, Koponen, Kivelä, et al., 
2018) who showed that the knock-out of ORP2 did not affect the expression of other 
oxysterol binding proteins in a significant way, whereas these results show that there has 
been significant downregulation of many oxysterol binding proteins in both samples. The 
downregulation of other oxysterol binding proteins could be a problem for downstream 
analysis since it could be hard to examine the effects of ORP2 KD if other similar proteins 
are also affected. 
Prediction of shRNA off-target effects 
Off-target prediction of shRNA is not a straightforward task and number of different 
variables have to be considered, in order to make confident predictions on the off-target 
effects. This fact is evident when the two different algorithms are compared, and this 
comparison clearly shows that probing for putative miRNA-like seed sequence targets in 
the 3’UTR regions of transcripts is not robust enough method to produce accurate 
predictions. The GESS algorithm is able to take into account more variables and it is able 
to perform statistical analysis in the prediction, therefore it identifies less off-targets. 
Controlling for off-target effects by removing any downregulated genes identified by 
GESS or the inhouse R script, might not be enough in some situations. There could be 
profound effects in biological functions if one of the off-targets was a gene that is crucial 
for a pathway, for example, unintentional KD of VEGFR2, which would affect the VEGFA-
VEGFR2 signaling pathway in unpredictable ways. Out of the off-targets predicted by 
GESS, genes LPP and CD47 are of most concern. Lipoma preferred partner (LPP) is 
associated with the promotion of motility and permeability in ECs (Leung et al., 2018) and 
Cluster of Differentiation 47 (CD47) is associated in apoptosis, proliferation, adhesion and 
migration as well as angiogenesis (Sick et al., 2012). CD47 downregulation can also lead 
to increased VEGFR2 downstream signaling (Xing et al., 2009). CD47 downregulation 
can only be seen in protrudin samples, and it is slightly upregulated in ORP2 samples. If 
indeed LPP has been downregulated due to off-target effects of the shRNA, there should 
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be downregulation in motility but instead mRNAs related to migration and motility seem 
to be upregulated. In the case of CD47 downregulation angiogenesis should be induced 
due to the reduction of thrombospondin-1 (THBS1) CD47 complexes, which inhibit cell 
migration, tube formation as well as NO stimulated response in ECs (Sick et al., 2012). 
The log2 fold change of THBS1 has been 0.63 and 0.61 in ORP2 and protrudin samples, 
respectively. The expression of THBS1 seems to be very similar in both samples and one 
could expect some compensatory effects in the expression of THBS1 in protrudin 
samples, if CD47 were abnormally downregulated. Previous experiments with knock-out 
ORP2 Huh7 cells by Kentala et al. (Kentala, Koponen, Kivelä, et al., 2018; Kentala, 
Koponen, Vihinen, et al., 2018) have also provided evidence that the knock-out of ORP2 
reduces cellular proliferation, migration and cell adhesion. A final conclusion on whether 
or not LPP and CD47 have been downregulated due to off-target effects cannot be made 
based on this data. However, a conclusion that their downregulation has likely not had a 
significant effect on the cellular functions of interest can be made; mostly due to the 
evidence provided by Kentala et al. and the fact that THBS1 expression is the same in 
both samples, even though CD47 has been downregulated only in protrudin KD samples. 
Gene ontology overrepresentation analysis 
GO-analysis suggests clear perturbation in the health of cells. This is very obvious from 
the enriched GO-terms, which all show a clear connection to biological functions that are 
related to the health of cells. These effects cannot be attributed to the lentiviral 
transduction nor puromycin selection of  cells, since control cells were subject to the same 
conditions. Therefore, there should not be any enrichment of these GO-terms due to the 
experimental protocol, and we have to assume that these results are due to the silencing. 
Since GO-terms that are related to angiogenesis in both samples and response to oxygen 
levels in ORP2 samples are overrepresented, these results would indicate that there have 
been major changes in genes related to angiogenesis. At first glance the GO-terms in 
ORP2 samples would seem to indicate that angiogenesis has been increased, since 
terms such as positive regulation of angiogenesis and response to decreased oxygen 
levels (i.e. hypoxia) are overrepresented. However, conclusions on the direction of 
regulation of the genes cannot be made based on overrepresentation of GO-terms alone 
and a more detailed analysis on the gene expression is required. The results would also 
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seem to indicate that there has been no perturbations in the transport of lipids, since there 
is no overrepresentation of GO-terms that are related to the transport and synthesis of 
lipids. Furthermore, the overrepresented GO-terms for ORP2 are similar to the ones 
obtained by Kentala et al. (Kentala, Koponen, Kivelä, et al., 2018). Most of the differences 
between the data presented here and data obtained in the aforementioned study are most 
likely due to the analysis being performed with Ingenuity Pathway Analysis (QIAGEN), 
since the curated gene sets might be different and also have different names. A more 
detailed analysis in to the genes and pathways related to the enriched GO-terms has to 
be made in order to find possible molecular changes. 
Gene set enrichment analysis with Wikipathways gene sets 
Examination of the GAGE predicted up- and downregulated pathways seem to indicate 
that angiogenesis has been upregulated. For example, angiogenesis related pathways 
such as the matrix metalloproteinases, VEGFA-VEGFR2 signaling pathway and focal 
adhesion-PI3K-Akt-mTOR-signaling pathway are all upregulated. There also seems to be 
some evidence to support the fact that angiogenesis has been perturbed in the 
downregulated pathways. For example, pathways related to the proliferation of cells seem 
to be downregulated, which would indicate that even though the cells are prompted to 
proliferate through the angiogenesis related pathways, they are not able to do so. Also, 
one of the indicators of angiogenesis is the switch from aerobic cell respiration to 
glycolysis in ECs, but the glycolysis pathway seems to be downregulated instead of 
upregulation. There also seems to be an effect in the synthesis of lipids, which was not 
seen in the GO-analysis, since the cholesterol biosynthesis pathway has been 
downregulated. This could be due to the lack of transport of cholesterol from the ER, 
which would increase the amount of cholesterol in the ER, and therefore the transcription 
of cholesterol biosynthesis genes is downregulated. There could also be some 
perturbation in the sensing of cholesterol at the ER and therefore the pathway has been 
downregulated. Also, the downregulation of SREBF2 and SREBF1 (transcription factors 
affecting the transcription of enzymes that synthesise sterols), which have fold changes 
of -0.5 or 0.09 and -0.2 or -0.77  in ORP2 and protrudin samples, respectively, could 
explain the reduction of cholesterol synthesis. 
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When the simplified angiogenesis pathway map is examined more closely, we can see 
that in fact the effect in this pathway has been the downregulation of downstream 
elements such as Akt1, NOS and MAPK1, which would indicate that angiogenesis has 
been reduced. Even though GAGE has flagged this pathway as upregulated, which is 
most likely due to the upregulation of most upstream elements in the pathway, such as 
VEGFA, HIF1A, VEGFR2, PDGFRA, PI3K and Ang 1, the aforementioned downstream 
elements are downregulated, and therefore the actual effect is likely reduced 
angiogenesis. This effect could be due to compensatory mechanisms in the cell, which 
are trying to initiate angiogenesis through these upstream elements. This compensatory 
effect is probably due to the fact that proliferation has been reduced along with the 
expression of the VEGFR1, and therefore VEGF stimulation is not being resolved. Since 
the VEGF stimulation is not being reduced by stalk cells producing VEGFR1, most cells 
are prompted to enter a tip cell-like phenotype, which could also explain the upregulation 
of VEGFR2 and PDGFRA. ECs are also prompted to migrate as either FAK, SMAD1 or 
p38 MAPK have been upregulated in both samples, even though proliferation has been 
reduced. This effect could also be explained by ECs transforming to the aforementioned 
tip cell-like phenotype, which would prompt the upregulation of migration related genes 
as well as the focal adhesion pathway. The downregulation of Akt1 and MAPK1 is the 
most likely explanation for the downregulation of the cell cycle, DNA replication and G1 
to S cell cycle control pathways. This effect can be explained by the downregulation of  
encoding cyclin D1 (CCDN1), among other cyclins, which is part of the PI3K-Akt pathway, 
and Akt1 is one of the downstream elements of this pathway. MAPK1, along with other 
downregulated MAPKs, such as MAPK8 and 9, also control the cell cycle through CCDN 
genes. Since the cells have are not entering S phase from G1 phase due to the 
downregulation of CCDN genes, it is quite reasonable to suggest that the DNA replication 
pathway is downregulated due to this effect. The downregulation of Akt1 and MAPK1 
could be explained with the ECs changing into the tip cell-like phenotype, which would 
prompt the cells reduce proliferation and therefore reduce signaling through the PI3K-Akt 
and MAPK pathways. 
As an alternative, the effects seen in the aforementioned pathways could also be due to 
the downregulation of other oxysterol binding proteins and the lack of endosomal 
transport to the PM due to reduced expression of protrudin. Among the downregulated 
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ORPs there are at least four (OSBPL3, OSBPL5, OSBPL6, OSBPL7), which bind 
cholesterol and/or PtdInPs as well as localise to the ER and PM and two ORPs, which 
bind to similar lipids and localise to endosomes as well as other membranes (OSBPL1A,  
OSBPL11) (Pietrangelo & Ridgway, 2018). This could result in the lack of precursors or 
signaling lipids at the PM because their transport has been reduced due to the lack of 
lipid transport between ER and endosomes, as well as the reduced endosomal transport 
to the PM. This could in turn result in the compensatory effect of the upregulation of signal 
mediators, such as PI3K, which would try to compensate for the lack of lipids by 
amplifying the speed of signal production. 
Another alternative hypothesis for the downregulation of the PI3K-Akt and MAPK 
pathways in ORP2 samples is related to the previously studied effects of ORP2 
interactions with Akt1 (Kentala, Koponen, Kivelä, et al., 2018; Kentala, Koponen, Vihinen, 
et al., 2018). Kentala et al. showed that ORP2 has a critical role in the formation of a 
complex that phosphorylates Akt1, which in turn affects multitude of cellular functions, 
such as proliferation, lamellipodia formation, migration, adhesion as well as glucose 
uptake and glycolysis. Therefore, the upregulation of the upstream elements in the PI3K-
Akt pathway could be compensatory effects due to the reduced downstream signaling 
through Akt1.  
Conclusions 
This thesis has provided evidence that the KD of ORP2 and protrudin have had significant 
and profound changes in mRNAs related to cholesterol biosynthesis, cell cycle, cell 
division and angiogenesis. These changes in mRNA levels, have most likely had a 
reducing effect in these biological functions. A common factor between the sample types 
that could explain these effects is the transformation of ECs to a tip cell-like phenotype, 
which would reduce proliferation and increase migration in ECs. In ORP2 silenced 
samples these effects could be due to the reduced phosphorylation of Akt1 and in 
protrudin samples these effects might be attributed to the reduced amount of endosomal 
trafficking from the ER to the PM. Results obtained in this thesis also indicate that ORP2 
KD has similar effects at the mRNA level in HUVECs as ORP2 knock-out has in Huh7 
cells (Kentala, Koponen, Kivelä, et al., 2018; Kentala, Koponen, Vihinen, et al., 2018). 
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Future prospects 
Verifying gene expression could be the first step towards further experimentation. RT-
qPCR could be used to examine the expression levels as an independent verification of 
the RNA-sequencing results. RT-qPCR does have some limitations and it is not able to 
detect as small changes as RNA-sequencing, but it is a very robust method to detect 
larger fold changes. RT-qPCR is also more error prone when compared to RNA-
sequencing and considering that most sequencing technologies are well established and 
subject to rigorous quality control, RT-qPCR may not be well motivated. Changes in gene 
expression might not translate to changes in protein levels, therefore it is crucial to verify 
the protein level changes of key nodes within the discussed pathways. Verifying protein 
levels is simple enough with Western blotting, but complications might arise if these 
proteins have long half-lives and changes in protein levels might not be seen in the span 
of a typical 72-hour KD experiment. Most crucial protein levels to verify are those of Akt1, 
MAPK1 and NOS. If these proteins have indeed been reduced in the silenced samples, 
further experiments might be warranted.  
There are at least three different assay types that can be used to study angiogenesis in 
vitro. These assays measure the rate of migration and proliferation as well as the 
differentiation of ECs.  Proliferation assays are quite simple to perform, since determining 
net cell numbers can be done using simple equipment. These experiments are quite 
straightforward, and they involve growing both control and silenced ECs in media 
supplemented with growth factors such as VEGF, and each cell type is counted 
periodically to determine their doubling rate. Other methods to study cell proliferation 
include methods, such as the xCELLigence system, which measures the impedance 
between electrodes that increases as cells divide on a plate populated with 
microelectrodes. Studying cell-cycle kinetics or measuring the amount of new double 
stranded DNA formation with either radioactively labelled thymine or with 
bromodeoxyuridine (BrdU) ELISA kit, which measures the amount of BrdU incorporated 
to new DNA, could also be used (Tahergorabi & Khazaei, 2012).  
Migration assays are more complex and involve more sophisticated equipment compared 
to a standard doubling rate proliferation assay. Most often a scratch assay or wound 
healing assay is used to quantify the migration rate of cells. This experiment is performed 
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by scoring a line in an EC monolayer, and cells around the scratch are monitored and 
their rate of migration to the empty area is measured. This measuring can be done 
periodically manually, or automated systems that track each cell can be employed 
(Tahergorabi & Khazaei, 2012).  
More complicated functional assays are the differentiation assays. These assays are 
used to determine the ECs ability for sprouting or tubulogenesis. These assays can be 
performed on thin 2D like matrixes or in 3D matrixes such as GrowDex or Matrigel. The 
ultimate goal is to quantify the length and number of new sprouts or microvessle-
resembling tubules growing within the matrix with a microscope (Tahergorabi & Khazaei, 
2012). Recent unpublished findings by the Olkkonen group from Minerva Foundation 
Institute for Medical Research have shown that the KD of ORP2 or protrudin inhibit tubular 
network formation in HUVECs (Koponen, et al., unpublished). 
Confirming whether or not the cholesterol biosynthesis pathway is downregulated due to 
cholesterol being trapped at the ER could be studied with at least two different methods. 
One of these methods includes studying the cleavage and localisation of SERBF2 (for 
example with Abnova, catalog number KA1378). Based on the localisation of SERBF2 to 
either the cytosol or to the nucleus, conclusions on the transcription of cholesterol 
biosynthesis related enzymes could be made. Cholesterol position in the ER could be 
confirmed with a cholesterol efflux assay, which uses radiolabelled cholesterol and 
measures cholesterol movement from cells to extracellular cholesterol acceptors (Low, 
Hoang, & Sviridov, 2012). 
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  Appendix 1 
 
R script used for shRNA off-target prediction 
library(biomaRt) 
library(dplyr) 
mart <- useMart("ensembl", dataset = "hsapiens_gene_ensembl")  
setwd("/Users/juusotaskinen/Desktop/Gradu/bioinfo/RNAseqstar/") 
# Only significantly DE genes are loaded 
ORP <-read.delim("ORP_DE_pathway_star/ORPsignificant.txt", 
stringsAsFactors=FALSE) 
PROT <- read.delim("PROT_DE_pathway_star/PROTsignificant.txt", 
stringsAsFactors=FALSE) 
# Find only down regulated genes 
PROT <- subset(PROT, PROT["log2FoldChange"]< 0) 
ORP <- subset(ORP, ORP["log2FoldChange"]< 0) 
# Find all the 3 UTR sequences associated with an ENSEMBL ID in each sample  
ORPsequences <- getSequence(id = ORP[“ENSEMBL],type= 
"ensembl_gene_id",seqType = "3utr",mart = mart) 
PROTsequences <- getSequence(id = PROT[“ENSEMBL],type= 
"ensembl_gene_id",seqType = "3utr",mart = mart) 
# Add seed sequences and 3’UTR sequences to a list  
seedORP <- "TTCCCGCC"  
seedPROT <- "TTACACCC" 
seeds <- list(seedORP,seedPROT) 
seq_idsORP <- cbind(ORPsequences[2],ORPsequences[1]) 
seq_idsPROT <- cbind(PROTsequences[2],PROTsequences[1]) 
seq_ids <- list(seq_idsORP,seq_idsPROT) 
offtargets <- c() 
# For loop which iterates over each sample and looks for the seed sequence in 
each 3’UTR sequence  
for(x in 1:length(seq_ids)){ 
  seq_id <- seq_ids[[x]] # Take sequence IDs of x sample in the list 
  tvect <- grepl(seeds[x],seq_id[,2],fixed = T) # See if seed sequence in 
list position x is in any of the 3’UTR sequences, and return FALSE or TRUE 
  seq_id <- cbind(seq_id,tvect) 
  seqid <- subset(seq_id, seq_id["tvect"] == TRUE) # Store ENSEMBL IDs with 
seed sequence in 3’UTR 
  offtargets[x] <- seqid #Add ENSEMBL IDs to output list 
} 
# Make list object into data frame columns to be used in merge() 
O <- data.frame(offtargets[1]) 
colnames(O) <- "ENSEMBL" 
P <- data.frame(offtargets[2]) 
colnames(P) <- "ENSEMBL" 
#### Find and save ensembl IDs with seed sequence from RNA-seq data 
ORPvsseed <- merge(ORP,O,by.x = "ENSEMBL", by.y = "ENSEMBL" , all = FALSE ) 
ORPvsseed <- ORPvsseed %>% distinct(symbol, .keep_all = TRUE) 
PROTvsseed <- merge(PROT,P,by.x = "ENSEMBL", by.y = "ENSEMBL" , all = FALSE ) 
PROTvsseed <- PROTvsseed %>% distinct(symbol, .keep_all = TRUE) 
write.table(ORPvsseed, file = "ORPseedfoundutr3.txt", sep = "\t",row.names 
=TRUE, quote = FALSE) 
write.table(PROTvsseed, file = "PROTseedfoundutr3.txt", sep = "\t",row.names 
=TRUE, quote = FALSE) 
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GAGE test statistics heatmaps 
 
 Up- and downregulated pathways in ORP2 silenced samples. Heat map shows the relative 
change in the pathways compared to control, where green shows the amount of relative 
downregulation and red shows the relative upregulation. 
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 Up- and downregulated pathways in protrudin silenced samples. Heat map shows the relative 
change in the pathways compared to control, where green shows the amount of relative downregulation 
and red shows the relative upregulation. 
